Literature DB >> 29488294

Agreement between paternal self-reported medication use and records from a national prescription database.

Jacqueline M Cohen1, Mollie E Wood2,3, Sonia Hernandez-Diaz1, Hedvig Nordeng2,3,4.   

Abstract

PURPOSE: Father's medication use is of interest in fertility studies and as negative control exposures in pregnancy medication safety studies. We sought to compare self-report to prescription records to understand how reliably each of these sources of information may be used.
METHODS: We compared self-reported medication use in the 6 months prior to pregnancy from fathers participating in the Norwegian Mother and Child Cohort Study to records of dispensed prescriptions from the Norwegian Prescription Database that overlapped in time. Medications from 3 main categories were assessed: prescription medications used chronically, prescription medications used episodically, and over-the-counter/prescription medications (predominantly obtained without prescription). We calculated agreement between self-report and dispensing records using Cohen's kappa statistic.
RESULTS: We included 42 848 pregnancies with the father's prescription data available for the 9 months before pregnancy. Prescription medications used chronically including antiepileptics, antipsychotics, and antidepressants showed substantial agreement between self-report and prescription records: kappa statistics 0.87, 0.63, and 0.74, respectively. Prescription medications used episodically like anti-infectives, opioids, anxiolytics, and hypnotics and sedatives showed worse agreement: kappa 0.19, 0.32, 0.40, 0.32. Over-the-counter/prescription medications like paracetamol and nonsteroidal anti-inflammatory drugs had slight agreement: kappa 0.02 and 0.20.
CONCLUSIONS: There is good agreement between paternal self-report and prescription data for prescribed medications used chronically and substantially less for medications used episodically. Suboptimal agreement for episodic medications suggests poor recall (for questionnaires) or false positives due to noncompliance (prescription data). Not surprisingly, use of medications available both with and without a prescription is not well captured using prescription databases alone.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Norwegian Mother and Child Cohort Study; Norwegian Prescription Database; exposure misclassification; medication use; paternal exposure; pharmacoepidemiology; validation study

Mesh:

Substances:

Year:  2018        PMID: 29488294     DOI: 10.1002/pds.4411

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  Comparison of Pharmacy Database Methods for Determining Prevalent Chronic Medication Use.

Authors:  Timothy S Anderson; Bocheng Jing; Charlie M Wray; Sarah Ngo; Edison Xu; Kathy Fung; Michael A Steinman
Journal:  Med Care       Date:  2019-10       Impact factor: 2.983

2.  Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-analysis.

Authors:  Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Myuri Ruthirakuhan; Parco Chan; Mirna Hennawy; Supriya Parikh; Simone Natalie Vigod; Cindy-Lee Dennis; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; Margaret Richter
Journal:  Can J Psychiatry       Date:  2020-03-09       Impact factor: 4.356

3.  A North American prospective study of depression, psychotropic medication use, and semen quality.

Authors:  Jennifer J Yland; Michael L Eisenberg; Elizabeth E Hatch; Kenneth J Rothman; Craig J McKinnon; Yael I Nillni; Greg J Sommer; Tanran R Wang; Lauren A Wise
Journal:  Fertil Steril       Date:  2021-05-07       Impact factor: 7.490

4.  Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals.

Authors:  Guillermo Prada-Ramallal; Fatima Roque; Maria Teresa Herdeiro; Bahi Takkouche; Adolfo Figueiras
Journal:  BMC Med Res Methodol       Date:  2018-09-27       Impact factor: 4.615

5.  Maternal use of thyroid hormone replacement therapy before, during, and after pregnancy: agreement between self-report and prescription records and group-based trajectory modeling of prescription patterns.

Authors:  Anna S Frank; Angela Lupattelli; David S Matteson; Hedvig Nordeng
Journal:  Clin Epidemiol       Date:  2018-12-03       Impact factor: 4.790

6.  Paternal antidepressant use as a negative control for maternal use: assessing familial confounding on gestational length and anxiety traits in offspring.

Authors:  Jacqueline M Cohen; Mollie E Wood; Sonia Hernández-Díaz; Eivind Ystrom; Hedvig Nordeng
Journal:  Int J Epidemiol       Date:  2019-10-01       Impact factor: 7.196

7.  Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross-Sectional Descriptive Study as Part of the PharmLines Initiative.

Authors:  Muh Akbar Bahar; Jens H J Bos; Sander D Borgsteede; Aafje Dotinga; Rolinde A Alingh; Bob Wilffert; Eelko Hak
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

8.  Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiation.

Authors:  Alesia M Jung; Stacey A Missmer; Daniel W Cramer; Elizabeth S Ginsburg; Kathryn L Terry; Allison F Vitonis; Leslie V Farland
Journal:  Fertil Res Pract       Date:  2021-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.